High-quality APIs. Zero disruption. Global reliability.

Meet us at Hall - 9.1 Booth - B48

28-30 October 2025
Messe Frankfurt, Germany

Phone

Our Team at CPHI Frankfurt 2025

Deepak Sapra

CEO, Pharmaceutical Services and Active Ingredients

Nirav Shah

Vice President, and Head, API - North Asia

Karun Gaur

Vice President And Head, Strategic Projects API

Dr. A Kalyan Chakravarthy

Executive VP & Head - SEAMEA & B2B Formulations

Kalpesh Modi

Vice President, and Head – EU Market, API & B2B Collaborations

E Sreedhar

Executive Vice President, API Regulatory Affairs

Gustavo Mayrink De Castro Marques

Vice President and Head, API Sales & Marketing, LATAM

Dr. NM Sekhar

Vice President, API R&D

R Lalitha Kumari

Global Head of API Product Management & Head of Sales - US & Canada

About Dr.Reddy’s API Business

We specialise in manufacturing and supplying a wide range of APIs for generic formulation manufacturers in India and overseas. The company has a diversified portfolio of 250+ active pharmaceutical ingredients, which are used in major therapeutic areas such as gastrointestinal, cardiovascular, diabetology, oncology, pain management, and dermatology. Our API manufacturing facilities adhere to cGMP (ICH Q7) and are inspected on a regular basis by international regulatory bodies. We have eight commercially inspected USFDA production plants, six in India and one each in Mexico and the United Kingdom.

Dr. Reddy's API business operates in a number of global markets, including the United States of America, Latin America, Europe, India, Russia, and other CIS nations.

250+ APIs
8 Manufacturing sites
1970+ drug master files across global markets.
Over 325 ANDAs
Filed4500+ patents globally, out of which 1125 have been granted.
Experience with complex APIs and formulations supporting early market entries.
Preferred pharma API supplier for pharma companies in more than 80 countries.

Sustainability

Sustainability is at the heart of our purpose. In FY2025, we served 756M+ patients, progressed to 60% carbon neutrality, and drew 68% of our power from renewables, all while staying water positive since FY2023.

We’re the only Indian pharma company to earn “A” scores in Climate Change, Water Security, and Supplier Engagement from CDP, and featured on the Dow Jones Sustainability World Index and S&P Global Sustainability Yearbook.

Our goals are clear:

100% renewable power by 2030
Carbon neutrality (Scope 1 & 2) by 2030
1.5B patients served by 2030

We innovate with care, scale with purpose, and act with accountability to shape a healthier world.

What we achieved in the past year:

Our Plants

About CPHI Frankfurt 2025

This flagship global event brings together 2,400+ exhibitors, 62,000+ pharma professionals, and cutting-edge innovations across APIs, biopharma, contract services, packaging, machinery, and more. It’s where the world’s pharmaceutical leaders connect to unlock new opportunities, strengthen partnerships, and stay ahead in a rapidly shifting global market. As part of this vibrant ecosystem, we’re excited to engage with peers, customers, and collaborators. We're here to create lasting value and help you if you're exploring dependable API partnerships, looking to scale your sourcing strategies, or seeking operational agility. Let’s meet at CPHI Frankfurt. We’re ready to support your next phase of growth with reliable, agile, and future-ready API solutions.